Finch Therapeutics Group - Chapter 11 Plan Terms

Finch Therapeutics Group’s liquidation plan centers on the $30 million cash sale of substantially all assets to Ferring Asset Holding, whereby allowed claims receive payment in full or other unimpaired treatment, remaining available cash—estimated at approximately $19 million, or $11.83 per share—is distributed pro rata to equityholders, and a plan administrator winds down the estates.

Plan Terms

Overview

Capital Structure and Case Funding

Sale Process

Ferring Sale Transaction

Sources of Consideration

Unclassified Claims and Expenses

Classification and Treatment of Claims and Interests

FTG Equity Distributions

Plan Administrator and Wind-Down

Executory Contracts and Unexpired Leases

Retained Causes of Action

Releases and Exculpation

Injunction

Insurance and Indemnification

Voting and Cramdown

Effective Date and Conditions Precedent

Tax Treatment